Oncology Servier’s ASCO 2025 data: Advancing IDH-mutated cancer treat... At ASCO 2025, Servier’s Becky Martin discusses IDH-mutated cancers, including key insights on Tibsovo & Voranigo, and the implications for patients.
News Top podcaster spread health misinformation, claims BBC probe Prominent podcaster Steven Bartlett has been accused of allowing health misinformation to be shared on his Diary of a CEO stream.
Digital Unlocking biotech insights: Top 10 podcasts you need to list... In the fast-paced world of biotechnology, staying informed and connected is key to success.
News FDA approves higher Wegovy dose via 4th priority voucher The US FDA has approved a fourth product via its new National Priority Voucher Programme -- a 7.2 mg dose of Novo Nordisk's weight loss drug Wegovy (semaglutide), to be marketed as Wegovy HD.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
